SCH also activated the NF-κB pathway by increasing the expression levels of TRAF6 and IRAK1 proteins and increasing the phosphorylation of IκBα and P65, thereby enhancing immunity. The gene discussed is TRAF6; the disease is spindle cell hemangioma.